This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Aetiology of intracerebral haemorrhage

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Acute or chronic arterial hypertension accounts for 40-50% of cases of spontaneous ICH. Rupture of Charcot-Bouchard aneurysms is the usual mechanism in chronic hypertensives.

However:

  • arterial rupture may occur in the absence of aneurysm
  • 50% of patients with spontaneous ICH have no history or clinical evidence of hypertension
  • acute rises in blood pressure may precipitate ICH in situations typically associated with hypertension. For example, drugs such as amphetamines and cocaine; exposure to extreme cold; trigeminal nerve stimulation; following carotid endarterectomy, correction of congenital heart lesions or heart transplantation

Other causes of spontaneous ICH include:

  • amyloid angiopathy - accounts for one third of cases in the elderly. Infiltration of amyloid into the arterial walls is associated with weakening of the small vessels in cerebral white matter and the subarachnoid space
  • vascular malformations - usually, arteriovascular malformations and cavernous angiomas; common in young normotensives
  • bleeding diastheses - thrombocytopenia, leukaemia, haemophilia; anticoagulant therapy, e.g. warfarin
  • head injury

Rare associations are:

  • systemic administration of fibrinolytics
  • reperfusion after brain infarction

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.